• Discuss the timeline of the development of treatment options for pulmonary hypertension (PH) including recently approved and treatment options currently in clinical trials.
• Identify presentation and management of pulmonary hypertension in patients with sarcoidosis.
• Explain the current approach to pulmonary hypertension in the presence of Hereditary Hemorrhagic Telangiectasia (HHT).